The fate of eyes with wet AMD beyond four years of anti-VEGF therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The fate of eyes with wet AMD beyond four years of anti-VEGF therapy
Authors
Keywords
Aflibercept, Intravitreal injections, Long-term treatment, Ranibizumab, Wet age-related macular degeneration, wAMD
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume 256, Issue 4, Pages 823-831
Publisher
Springer Nature
Online
2018-02-04
DOI
10.1007/s00417-018-3907-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration
- (2016) Marion R. Munk et al. ACTA OPHTHALMOLOGICA
- Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
- (2016) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
- (2016) F G Holz et al. EYE
- Ranibizumab et dégénérescence maculaire liée à l’âge exsudative : analyse multicentrique à 5ans des résultats fonctionnels et anatomiques en pratique clinique réelle
- (2016) E. Boulanger-Scemama et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Makula-Atrophie bei feuchter altersabhängiger Makuladegeneration
- (2016) J. G. Garweg OPHTHALMOLOGE
- Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)
- (2016) Robert B. Bhisitkul et al. OPHTHALMOLOGY
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment
- (2016) Laura Kuehlewein et al. Ophthalmic Surgery Lasers & Imaging Retina
- Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland
- (2015) S Borooah et al. EYE
- Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting
- (2015) E. Boulanger-Scemama et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Langzeit-Verlauf bei Patienten mit intravitrealer Anti-VEGF Therapie für neovaskuläre AMD
- (2015) C. Amstutz et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
- (2015) Marc C. Peden et al. OPHTHALMOLOGY
- Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration
- (2015) Mark C. Gillies et al. OPHTHALMOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Long-term longitudinal study of patients treated with ranibizumab for neovascular age-related macular degeneration
- (2014) Annette Rasmussen et al. CURRENT OPINION IN OPHTHALMOLOGY
- Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study
- (2014) Emily Y. Chew et al. JAMA Ophthalmology
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration
- (2013) Robert P. Finger et al. SURVEY OF OPHTHALMOLOGY
- Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
- (2012) Philipp S. Muether et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Turning a blind eye to anti-VEGF toxicities
- (2012) Susan E. Quaggin JOURNAL OF CLINICAL INVESTIGATION
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started